A new role for neutrophils during sepsis: Target and source of interleukin-12;Un rôle nouveau pour les polynucléaires neutrophiles au cours du sepsis: Cible et source d'interleukine-12

Annales Francaises d'Anesthesie et de Reanimation

Volumn 23, Issue 2, 2004, Pages 132-137

  Ethuin, F ^a,b   Chollet Martin, S ^b   Jacob, L ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Interleukine 12; Polymorphonuclear Neutrophil; Polynucl aire neutrophile; Sepsis

Indexed keywords

INTERLEUKIN 12;

ACUTE PHASE RESPONSE; ANTIGEN SPECIFICITY; AUTOCRINE EFFECT; BACTERIAL INFECTION; CYTOKINE RELEASE; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; INFECTION SENSITIVITY; INFLAMMATORY INFILTRATE; LEUKOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; NEUTROPHIL CHEMOTAXIS; POLYMORPHONUCLEAR CELL; REVIEW; SEPSIS; TARGET CELL;

EID: 1642379530     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2003.11.014     Document Type: Short Survey

References (42)

1. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 170:1989;827-839.
2. Trinchieri G., Gerosa F. Immunoregulation by interleukin-12. J Leukoc Biol. 59:1996;505-511.
3. Cassatella M.A., Meda L., Gasperini S., D'Andrea A., Ma X., Trinchieri G. Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol. 25:1995;1-5.
4. Bliss S.K., Marshall A.J., Zhang Y., Denkers E.Y. Human polymorphonuclear leukocytes produced IL-12, TNF-α, and the chemokines macrophage-inflammatory protein-1α and 1β in response to Toxoplasma gondii antigens. J Immunol. 162:1999;7369-7375.
5. Ma X., Riemann H., Trinchieri G. Positive and negative regulation of interleukin-12 gene expression. Eur Cytokine Netw. 9:1998;54-64.
6. Mattner F., Fischer S., Guckes S., Jin S., Kaulen H., Schmitt E., et al. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol. 23:1993;2202-2208.
7. Ling P., Gately M.K., Gubler U., Stern A.S., Lin P., Hollfelder K., et al. Human IL-12p40 homodimer binds to the IL-12 receptor but does not mediate biologic activitiy. J Immunol. 154:1995;116-127.
8. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 84:1995;4008-4027.
9. Chehimi J., Starr S.E., Frank I., D'Andrea A., Ma X., MacGregor R.R., et al. Impaired interleukin-12 production in human immunodeficiency virus-infected patients. J Exp Med. 179:1994;1361-1366.
10. Clerici M., Lucey D.R., Berzofsky J.A., Pinto L.A., Wynn T.A., Blatt S.P., et al. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science. 262:1993;1721-1724.
11. Altare F., Durandy A., Lammas D., Emile J.F., Lamhamedi S., Le Deist F., et al. Impairment of mycobacterial immunity in human interleukine 12 receptor deficit. Science. 280:1998;1435-1438.
12. Altare F., Jouanguy E., Lamhamedi S., Doffinger R., Fischer A., Casanova J.L. Mendelian susceptibility to mycobacterial infection in man. Curr Opin Immunol. 10:1998;413-417.
13. Hensler T., Heidecke C.D., Hecker H., Heeg K., Bartels H., Zantl N., et al. Increased susceptibility to postoperative sepsis in patients with impaired monocytes IL-12 production. J Immunol. 161:1998;2655-2659.
14. Ertel W., Keel M., Neidhardt R., Steckholzer U., Kremer J.P., Ungethuem U., et al. Inhibition of the defense system stimulating interleukin-12 interferon-γ pathway during critical illness. Blood. 5:1997;1612-1620.
15. Karp C.L., Wysocka M., Ma X., Marovich M., Factor R.E., Nutman T., et al. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol. 28:1998;3128-3136.
16. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 7:1994;2068-2101.
17. Hampton M.B., Kettle A.J., Winterbourn C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 92:1998;3007-3017.
18. Cassatella M.A. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol. 73:1999;369-509.
19. Grenier A., Dehoux M., Boutten A., Arce-Vicioso M., Durand G., Gougerot-Pocidalo M.-A., et al. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood. 4:1999;1413-1421.
20. Grenier A., Chollet-Martin S., Crestani B., Delarche C., El Benna J., Boutten A., et al. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood. 99:2002;2997-3004.
21. Reglier H., Arce-Vicisio M., Fay M., Gougerot-Pocidalo M.A., Chollet-Martin S. Lack of IL-10 and IL-13 production by human polymorphonuclear neutrophils. Cytokine. 10:1998;192-198.
22. Collison K., Saleh S., Parhar R., Meyer B., Kwaasi A., Al-Hussein K., et al. Evidence for IL-12-activated Ca2+ and tyrosine signaling pathways in human neutrophils. J Immunol. 161:1998;3737-3745.
23. Fong Y., Lowry S. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol. 55:1990;157-170.
24. Lauw F.N., Dekkers P.E.P., Te Velde A.A., Speelman P., Levi M., Kurimoto M., et al. Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in Chimpanzees. J Infect Dis. 179:1999;646-652.
25. Allavena P., Paganin C., Zhou D., Bianchi G., Sozzani S., Mantovani A. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood. 184:1994;2261-2268.
26. Ethuin F., Delarche C., Benslama S., Gougerot-Pocidalo M.-A., Jacob L., Chollet-Martin S. Interleukin-12 increases interleukin-8 production and release by human polymorphonuclear neutrophils. J Leukol Biol. 70:2001;439-446.
27. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 101:1992;1644-1655.
28. Krutzik S.R., Sieling P.A., Modlin R.L. The role of Toll-like receptors in host defense against microbial infection. Curr Opin Immunol. 13:2001;104-108.
29. Wunderink R.G., Waterer G.W., Cantor R.M., Quasney M.W. Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia. Chest. 121:2002;87S.
30. Parillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med. 328:1993;1471-1477.
31. Koomans H.A., Boer W.H. Causes of oedema in the intensive care unit. Kidney Inter. (59 Suppl):1997;S105-S110.
32. Eichacker P.Q., Parent C., Kalil A., Esposito C., Cui X., Banks S.M., et al. Risk and efficacy of antiinflammatory agents in sepsis: restrospective and confirmatory studies. Am J Respir Crit Care Med. 166:2002;1197-1205.
33. Chollet-Martin S., Montravers P., Gibert C., Elbim C., Desmonts J.M., Fagon J.Y., et al. Subopulation of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome. Role of cytokine production. Am Rev Respir Dis. 146:1992;990-996.
34. Grundmann U., Rensing H., Adams H.-A., Falk S., Wendler O., Ebinger N., et al. Endotoxin desensitization of human mononuclear cells after cardiopulmonary bypass. Anesthesiology. 93:2000;359-369.
35. Faist E., Wichmann M., Kim C. Immunosuppression and immunomodulation in surgical patients. Curr Opin Crit Care. 3:1997;293-298.
36. Granowitz E.V., Porat R., Mier J.W., Orencole S.F., Kaplanski G., Lynch E.A., et al. Intravenous endotoxin supresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol. 151:1993;1637-1645.
37. Wakefield C.H., Cary P.D., Foulds S., Monson J.R.T., Guillou P.J. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg. 80:1993;205-209.
38. Marie C., Muret J., Fitting C., Losser M.R., Payen D., Cavaillon J.M. Reduced ex vivo interleukin-8 production by neutrophils in septic and non septic systemic inflammatory response syndrome. Blood. 9:1998;3439-3446.
39. Chollet-Martin S., Jourdain B., Gibert C., Elbim C., Chastre J., Gougerot-Pocidalo M.A. Interactions between neutrophils and cytokines in blood and alveolar space during ARDS. Am J Resp Crit Care Med. 153:1996;594-601.
40. Steinhauser M.L., Hogaboam C.M., Kunkel S.L., Lukacs N.W., Strieter R.M., Standiford T.J. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol. 162:1999;392-399.
41. Christou N.V. Host-defense mechanisms in surgical patients: a correlative study of the delayed hypersensitivity skin-test response, granulocytes function and sepsis. Can J Surg. 28:1989;39-46.
42. Ethuin F., Delarche C., Gougerot-Pocidalo M.-A., Eurin B., Jacob L., Chollet-Martin S. Selective regulation of interleukin-12 p40 and p70 production by blood and alveolar phagocytes from patients with severe sepsis. Lab Invest. 83:2003;1353-1360.